$LIXT News Article - LIXTE Biotechnology Announces
Post# of 31
(Total Views: 96)
Posted On: 09/20/2023 10:10:55 AM
$LIXT News Article - LIXTE Biotechnology Announces a Supported Collaborative Trial to Study LIXTE's First-in-Class PP2A Inhibitor, LB-100, Plus GSK's Immunotherapy, Dostarlimab, in Clear-Cell Ovarian Cancer https://marketwirenews.com/news-releases/lixt...27609.html
(0)
(0)Lixte Biotechnology Holdings, Inc. (LIXT) Stock Research Links
My Twitter: WhyteStocks
Scroll down for more posts ▼